US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist
  • 0.5414
  • +0.0015+0.28%
Trading Dec 26 11:46 ET
2.65MMarket Cap-0.01P/E (TTM)

NovaBay Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NovaBay Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.000M--
--2024/Q4-- / 2.500M--
--2024/Q32.441M / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.000M--
--2024/Q4-- / 2.500M--
--2024/Q32.441M / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--

Unlock Free Earnings Estimates

NovaBay Pharmaceuticals Earnings Reports

  • NovaBay Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:20

  • NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:15

  • NovaBay Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 10 04:22

  • NovaBay Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 29 23:02

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data